Mutation of GATA3 is frequently observed in breast cancer, and its expression is lost in mouse models of breast cancer and in upper tract urothelial carcinoma (Takaku et al., 2015; Wang et al., 2019). This evidence concerns the gene GATA3 and renal pelvis/ureter urothelial carcinoma.